Literature DB >> 8774690

Sequence analysis of a parvovirus B19 isolate and baculovirus expression of the non-structural protein.

K E Hicks1, R C Cubel, B J Cohen, J P Clewley.   

Abstract

Serology for parvovirus B19 has been hampered by limited availability of antigen which has often had to be isolated from viraemic blood donations. We have determined the sequence of the genome of one such isolate (Stu). It is 99% similar to the sequences of two other isolates (Wi and Au) except at the far 5'-end, where it is more similar to the terminus of another isolate (Ala/Alb). Recombinant nonstructural protein, NS, was constructed. Antibodies to NS, as well as to the capsid proteins, VP1/2, were detected in patients with B19 infection.

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8774690     DOI： 10.1007/bf01718833

Source DB:  PubMed          Journal:  Arch Virol        ISSN： 0304-8608            Impact factor:   2.574


  27 in total

1.  Two anti-parvovirus B 19 IgM capture assays incorporating a mouse monoclonal antibody specific for B 19 viral capsid proteins VP 1 and VP 2.

Authors:  H J O'Neill; P V Coyle
Journal:  Arch Virol       Date:  1992       Impact factor: 2.574

2.  Cloning of the human parvovirus B19 genome and structural analysis of its palindromic termini.

Authors:  V Deiss; J D Tratschin; M Weitz; G Siegl
Journal:  Virology       Date:  1990-03       Impact factor: 3.616

3.  Blood donor screening for parvovirus B19.

Authors:  B J Cohen; A M Field; S Gudnadottir; S Beard; J A Barbara
Journal:  J Virol Methods       Date:  1990-12       Impact factor: 2.014

4.  Intrauterine parvovirus infection associated with hydrops fetalis.

Authors:  T Brown; A Anand; L D Ritchie; J P Clewley; T M Reid
Journal:  Lancet       Date:  1984-11-03       Impact factor: 79.321

5.  The gene encoding the nonstructural protein of B19 (human) parvovirus may be lethal in transfected cells.

Authors:  K Ozawa; J Ayub; S Kajigaya; T Shimada; N Young
Journal:  J Virol       Date:  1988-08       Impact factor: 5.103

6.  Candidate recombinant vaccine for human B19 parvovirus.

Authors:  G P Bansal; J A Hatfield; F E Dunn; A A Kramer; F Brady; C H Riggin; M S Collett; K Yoshimoto; S Kajigaya; N S Young
Journal:  J Infect Dis       Date:  1993-05       Impact factor: 5.226

7.  In vitro propagation of parvovirus B19 in primary foetal liver culture.

Authors:  K E Brown; J Mori; B J Cohen; A M Field
Journal:  J Gen Virol       Date:  1991-03       Impact factor: 3.891

Review 8.  Human parvoviruses.

Authors:  L J Anderson
Journal:  J Infect Dis       Date:  1990-04       Impact factor: 5.226

9.  Diagnostic assays with monoclonal antibodies for the human serum parvovirus-like virus (SPLV).

Authors:  B J Cohen; P P Mortimer; M S Pereira
Journal:  J Hyg (Lond)       Date:  1983-08

10.  Parvovirus-like particles in human sera.

Authors:  Y E Cossart; A M Field; B Cant; D Widdows
Journal:  Lancet       Date:  1975-01-11       Impact factor: 79.321
View more
  6 in total

1.  Development of a hypersensitive detection method for human parvovirus B19 DNA.

Authors:  K Sato; E Matsuda; K Kamisango; H Iwasaki; S Matsubara; Y Matsunaga
Journal:  J Clin Microbiol       Date:  2000-03       Impact factor: 5.948

2.  Genetic diversity within human erythroviruses: identification of three genotypes.

Authors:  Annabelle Servant; Syria Laperche; Francis Lallemand; Valérie Marinho; Guillemette De Saint Maur; Jean François Meritet; Antoine Garbarg-Chenon
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

3.  Evidence for the role of demyelination, HLA-DR alleles, and cytokines in the pathogenesis of parvovirus B19 meningoencephalitis and its sequelae.

Authors:  J R Kerr; F Barah; M L Chiswick; G V McDonnell; J Smith; M D Chapman; J B Bingham; P Kelleher; M N Sheppard
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-12       Impact factor: 10.154

4.  Novel human erythrovirus associated with transient aplastic anemia.

Authors:  Q T Nguyen; C Sifer; V Schneider; X Allaume; A Servant; F Bernaudin; V Auguste; A Garbarg-Chenon
Journal:  J Clin Microbiol       Date:  1999-08       Impact factor: 5.948

5.  Reactivity of genotype-specific recombinant proteins of human erythrovirus B19 with plasmas from areas where genotype 1 or 3 is endemic.

Authors:  Armen Parsyan; Shane Kerr; Shirley Owusu-Ofori; Gordon Elliott; Jean-Pierre Allain
Journal:  J Clin Microbiol       Date:  2006-04       Impact factor: 5.948

Review 6.  Human parvovirus B19.

Authors:  Erik D Heegaard; Kevin E Brown
Journal:  Clin Microbiol Rev       Date:  2002-07       Impact factor: 26.132
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.